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Abstract 
 
AIMS: To review our experiences with giant mandibular ameloblastoma (GMA) over a 5-year period, and to 
formulate a treatment algorithm for managing this tumour. 
 
METHODS: We retrospectively reviewed all GMA patients who underwent segmental mandibulectomy and 
immediate free fibular osteoseptocutaneous flap reconstruction (SM-IFFOFR) by a single reconstructive team 
from 2002 to 2006. All treatment methods and outcomes were analysed. 
 
FINDINGS: Forty-four ameloblastoma patients were operated during this study period. Sixteen cases had 
GMA, of which 9 patients were included in this series (mean age: 35 years). The defects in the mandible 
ranged from 7 to 16 cm in length (mean: 12 cm). The average length of the harvested fibula was 11 cm, and the 
number of osteotomies ranged from 1 to 2. The mean ischemic time was 137 minutes (range: 90-180 minutes). 
Neck recipient vessels were used for flap perfusion in all cases. All but one flaps were viable without any 
complications, whilst partial skin-island necrosis occurred in 2 patients. Hospital stay was 2 weeks in most of 
the patients. No tumour recurrence was found during the follow-up period (range: 26-73 months). Dental 
implants were placed in 2 patients. 
 
CONCLUSIONS: Despite several limitations of this study, we suggest that a radical approach with the SM-
IFFOFR is an effective treatment for GMA. Further well-designed, larger series with longer follow-up periods 
are still encouraged. 
 
 
Key words: Giant ameloblastoma; jaw tumour; microvascular surgery; immediate reconstruction; fibular 
free flap 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ARTICLE IN PRESS
 3 
Introduction 
 
 Ameloblastoma is a benign odontogenic tumour of the jaws with a locally aggressive behaviour and a 
high recurrent rate. In general, ameloblastoma can be categorised into 3 types: conventional solid multicystic, 
unicystic and peripheral ameloblastoma. Conventional ameloblastoma is a slow growing, but locally invasive, 
tumour. Some ameloblastomas become gigantic and destroy adjacent tissues. Conversely, unicystic 
ameloblastoma frequently occurs in younger populations, and possesses a less aggressive nature and a lower 
recurrent rate. It can be either a tumour de novo or a tumour arising from an odontogenic cyst. Both solid and 
unicystic ameloblastoma commonly occur in the mandible, especially the molar-ramus area.1-6  
Various therapies for ameloblastoma have been reported. However, the universally accepted approach 
remains unsettled. It can range from conservative treatments, such as enucleation with or without curettage, to 
aggressive treatments which include peripheral ostectomy and resection.1,2,7 Once mandibular ameloblastoma 
becomes gigantic, it requires a radical approach.2,3 Free flap reconstruction is necessary when the resected 
defect is larger than 5 cm. Some authors reported the treatment of extensive ameloblastoma using radical 
excision with immediate microvascular reconstruction.4-6  
Until now, there has been neither definition of nor definite treatment consensus on giant mandibular 
ameloblastoma (GMA). In this paper, GMA is defined as mandibular ameloblastoma which consists of three 
components: 1) large size (> 5 cm in length), 2) thinning of the inferior and/or posterior mandibular borders, 
and 3) considerable jaw expansion. The aim of this study was to review our experiences with this tumour over a 
5-year period, and to institute an algorithm for managing GMA.  
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Methods 
 
 We retrospectively reviewed all ameloblastoma patients treated between 2002 and 2006 at the Pitié-
Salpêtrière University Hospital. In our department, one of 2 microsurgical teams used an osteomyocutaneous 
flap for reconstructing the resected jaws, whereas our team favoured an osteoseptocutaneous flap. Had we 
included the patients treated by the other team, our study results would have been skewed. Hence, we decided 
to analyse our GMA patients only. 
All the patients in this series received segmental mandibulectomy and immediate free fibular 
osteoseptocutaneous flap reconstruction (SM-IFFOFR) via a transcervical route. Leg angiography was 
performed preoperatively to detect any anatomical variation or pathology of the peroneal circulation. The 
extent of resection depended upon the tumour size and the extent of destruction in computed tomography (CT). 
We used the Gilbert’s lateral approach 8 and the muscle-sparing technique 9 under tourniquet for flap 
harvesting. The skin island was centred at the middle and/or lower thirds, and its size depended upon recipient 
needs. All the dissections and microanatomoses of the fibular free flap (FFF) were performed or closely 
controlled by the senior consultant (AC).  
The clinical data were obtained through chart reviews and included age at presentation, sex, tumour 
location, date and extent of resection, flap ischemia time, fibular bone length, skin paddle size, amount of graft 
osteotomy, recipient vessels, anticoagulant regimen, length of hospital stay, surgical complications, date of 
tumour recurrence, and date of last follow-up visit. The two independent assessors (AC and PP) evaluated the 
clinical outcomes. If agreement could not be reached, advice was sought from a third party. 
 The recommendations of the Helsinki declaration were thoroughly maintained during this study. 
Ethical approval was exempted by the Committee of Human Subject Protection in Biomedical Research 
(Comité de Protection des Personnes: CPP) of Paris and its suburb, whilst we followed the national guideline 
‘Déclaration de Commission Nationale de l’Informatique et des Libertés (CNIL)’ to protect the patient 
confidentiality.  
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Findings 
 
 Forty-four ameloblastoma patients were identified during the study period. Of those, 16 patients had 
GMA, of which 9 patients underwent SM-IFFOFR by our team. The mean age of the patients (8 men and 1 
woman) was 35 years (range: 18-70 years). The defects ranged from 7 to 16 cm in length (mean: 12 cm). 
According to the classification by Jewer et al 10, we included 5 H, 2 LCL, 2 LC defects (H = hemimandible 
segment that involves the condyle, L = lateral segments without the condyle, C = central segments that includes 
both canine teeth).  
The average length of the harvested fibula was 11 cm, and the skin paddle size ranged from 22 to 70 
cm2. We osteotomised the grafts on the bench to prepare their curvature. Without the use of a preoperative 
template, we did one osteotomy in 3 flaps, and two osteotomies were performed in the remaining. We used 
miniplates and screws to fix each osteotomy site and between the FFF and the native mandible.  
The flap artery and 2 veins were anastomosed to the recipient vessels (5 with facial artery, 2 with 
superior thyroid artery, and 1 with lingual artery; 4 with facial vein, 2 with superior thyroid vein, 2 with 
thyrolinguofacial trunk, and 1 with internal jugular vein). No autogenous vein graft was used. The thyrocervical 
trunk and internal jugular vein were anastomosed using the end-to-side technique, whereas the other vessels 
were anastomosed end-to-end. All the donor and recipient vessels were topically irrigated by heparinised saline 
solution. Return of flap circulation was judged by bleeding of periosteal bone and a soft-tissue cuff. The mean 
ischemic time was 137 minutes (range: 90-180 minutes). Donor sites were closed primarily in 6 patients and 
with a split-thickness skin graft in the remaining of the patients. 
Postoperatively, pharmacologic regime was low-molecular-weight heparin during the first few days 
for deep vein thrombosis prophylaxis. Four patients received an intermaxillary fixation for 3-8 weeks to control 
jaw position and to stabilise osteosynthesis materials. Patients began self-ambulation with crutches 3-5 days 
postoperatively. Hospital stay was 2 weeks in all except 2 patients. The prolonged hospitalisation was due to 
major complications: 1 grave haematoma and 1 failed flap.  
 Complete flap survival was 8 out of 9 flaps, and partial skin-island loss occurred in 2 patients. A failed 
flap occurred one week postoperatively because of flap necrosis and subsequent infection, requiring transplant 
removal. Although a repeat flap transfer was possible,3 the patient gained his weight 30 kg a few months after 
operation. This made repeat FFF more difficult, so we chose to perform secondary non-vascularised iliac 
grafting.  
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No serious complications were found in all cases, except a conspicuous scar at the donor sites. 
Postoperative facial appearances, assessed by the method of Boyd et al 11, were fair or excellent. Only 2 
patients received implant-supported rehabilitation. There has been no tumour recurrence to date. The follow-up 
duration was 53 months on average (range: 26-73 months). 
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Discussion 
 
1. A rational approach for treating ameloblastoma 
 
Ameloblastoma is a benign, but locally aggressive, odontogenic tumour. A conservative approach 
usually yields a high recurrent rate, thereby requiring close vigilance. Repeat treatment of a small recurrence is 
more acceptable than jaw amputation with complex reconstructive surgery. An extensive tumour may be 
destructive and life-threatening, necessitating adequate excision which depends upon its site and extension. 
Because of the infiltrative lesion characteristics, radical resection is favourable with the aid of preoperative CT. 
The tumour border is always beyond the macroscopic surface and the radiographic boundaries. Thus, removal 
of uninvolved bone 1 to 2-cm beyond the clinical tumour margin, is of great help to ensure clearance from 
microscopic infiltration.2-7 All involved teeth must be removed because small tumour islands can persist within 
the periodontal ligament.12 
We established an algorithm for managing mandibular ameloblastoma (Fig. 1). Although the 
distinction between ‘persistence’ and ‘recurrence’ following a conservative approach remains unclear,3 clinical 
findings of individual patient dictates the treatment for each patient. We believe that conservative treatment 
creates higher quality of life. Thus, it should be used (in conjunction with adequate postoperative surveillance) 
before more radical therapies. However, GMA patients are suited for the SM-IFFOFR whenever feasible (Fig. 
2). We avoid using a lip split incision in Blacks because of a high incidence of a hypertrophic scar and keloid.13 
Supraperiosteal dissection with/without excision of overlying mucosa is indicated if the tumour perforates 
cortices.3 
We agree with the suggestion by Bui et al 14 that delayed or secondary reconstruction should be the 
treatment of choice in medically unstable patients, or when there are no local options such as available recipient 
vessels. However, a history of previous surgery probably makes the success of secondary reconstruction drop 
considerably. This may be due to scarring and fibrosis secondary to earlier surgery. Besides, the creation of a 
tunnel for the neocondyle during the secondary reconstruction may endanger the facial nerve.15  
Recurrences of ameloblastoma commonly occur during the 5-year postoperative period.5 Hence, 
patient follow-up using clinical examination and panoramic radiograph should be done twice a year in the first 
5 years and then once a year for at least 10 years.2,6 Patients undergoing the SM-IFFOFR necessitate more 
frequent follow-up during the first-year postoperative course.  
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2. Considerations on the SM-IFFOFR 
 
2.1 Advantages 
 
SM-IFFOFR eradicates the tumour, lowers the recurrence rate, restores the function via placement of 
vascularised tissues into the defect, provides primary bone healing, reduces the risk of scarring, contraction and 
fibrosis, and creates high quality of life.2,5,15,16 Reconstruction of segmental mandibular defects requires the 
restoration of jaw continuity, osseous bulk, bone quality, aesthetic facial form, alveolar bone height, and soft 
tissue (that enhances tongue mobility, speech, swallowing and subsequent dental rehabilitation).15-18 Osseous 
free flaps for mandibular reconstruction can be obtained from the fibula, ilium, scapula, rib, metatarsus and 
radius.15,17  
FFF provides several advantages over other donor sites. These include ample bone length, ease of 
graft dissection and contouring, a two-team approach, long pedicles with large calibre vessels, and minimal 
donor-site morbidity. Its vascular supply is recipient-independent. Owing to the profuse periosteal blood 
supply, careful osteotomising the flap rarely harms its vascularity. Moreover, this flap offers excellent 
bicortical bone stock for dental implant placement and a versatile cutaneous unit for soft-tissue 
reconstruction.9,15-17,19-24 Once dehiscence occurs, the vital periosteum accelerates the re-epithelialisation and 
healing.16 The muscle-sparing technique diminishes the donor-site dead space and subsequent haematoma, 
reduces the risk of the pedicle damage, promotes the skin-island pliability, and preserves the donor limb 
strength.9 A precondition for the graft curvature, although time-consuming, is frequently coped with the gradual 
learning curve. In the disarticulated patients, condylar reconstruction using the distal end of the FFF is possible 
without damage to the vascular pedicle.24 
Pogrel et al 25 reported the higher success rate of the FFF for mandibular defects more than 9 cm in 
length, compared with free bone grafts. Non-vascularised bone grafting is indicated only for small defects less 
than 5 cm in non-irradiated tissue and/or in medically unfit patients to tolerate microvascular head and neck 
reconstruction (MHNR) or when a defect includes bone only.4,21 
The skin island of the FFF is usually sufficient for both skin and oral lining. However, in case of 
extensive soft-tissue loss, a double-free flap procedure 20 or a concomitant locoregional flap 23 may be 
considered. It is generally accepted that FFF and dental implant treatment are worthwhile procedures for 
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oncologic patients.4-6,15,19,20 However, only 2 patients in this series received this treatment due to a lack of the 
reimbursement of dental implant therapy in France. 
 
2.2 Technical refinements 
 
2.2.1 Perforators and skin paddle harvesting 
 
 Schusterman et al 18 demonstrated that 16 of 80 legs lacked septocutaneous branches. Nonetheless, all 
of our patients presented with significant-sized septal perforators. A muscular cuff of soleus and/or flexor 
hallucis longus (FHL) should be included in the flap when the septal branches are absent. Excessive soft-tissue 
incorporation causes flap bulk, and the FHL dissection is related to restriction in dorsiflexion and plantarflexion 
of the big toe.9,26 Notably, musculocutaneous perforators are more abundant and proximal than the septal 
branches.18 In this respect, a skin paddle of the septocutaneous FFF should be located in the middle and distal 
thirds of the leg, and may be divided based on the separate perforating vessels.27 When the paddle size is 
excessive, it can be de-epithelialised with the preservation of the perforators to maintain the vasculature. 
Conversely, the skin flap can be abandoned in bone-only reconstruction. 
 
2.2.2 Compromised vascularity and free flap failure 
 
It remained unknown about the cause of the failed flap in our series because no sign of compromised 
vascularity was observed. Skeletonising the FFF using the muscle-preserving technique does not substantially 
affect the blood supply.9 In our 2 patients with partial skin-island necrosis, the epidermis alone was denuded. 
The underlying tissues remained viable and the healing was uneventful. 
The rate of free flap failure was approximately 1-15%, and was related to the patients’ general health, 
age, previous history of surgery, cigarette smoking, nutritional status and long operative time.19,22,28 The early 
recognition and timely management of flap complications is necessary because of a narrow window of 
opportunity to salvage potential flap failure.14 A large series by Bui et al 14 revealed many factors involving 
venous thrombosis following MHNR, including the use of a vein graft, kinking or compressing of the veins 
with tight skin closure, neck motion, and end-to-end venous anastomoses. Arterial thrombosis was less 
common in that series. Without timely recognition, venous thrombosis would evolve into arterial thrombosis 
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and subsequent no-reflow phenomenon. Thrombosis frequently occurs during the first 5 days following 
MHNR, necessitating close surveillance. Suh et al 28 found that the success of MHNR chiefly depended upon 
good pedicle orientation. To the best of our experiences, we recommend the reconstruction with a long pedicle 
containing the largest calibre vessels available (an external diameter exceeding 2 mm) without the use of a vein 
graft, and the end-to-side anastomoses of the veins. 
 
2.2.3 Limited height of the neomandible 
 
Height deficiencies of the FFF worsen vertical discrepancy between the graft segment and the dental 
occlusal plane. This also cause poor crown-root ratio of dental implants. Moreover, insufficient bone height in 
the symphyseal region precedes loss of chin projection and lip support.15,20 The ‘double barrel’ technique 16,29 
or alveolar distraction 30 can solve this problem. Otherwise, the vascularised iliac crest flap is an excellent 
option.20  
In our department, we have now used the ‘double barrel’ technique to facilitate alveolar 
reconstruction.29 The fibula can be harvested as long as possible with the protection of the distal tibiofibular 
joint stability by preserving over 6 cm of the distal fibula. Perpendicular osteotomies of the FFF and further 
folding must respect the fibular vasculature during the double-strut grafting. To avoid a cross-bite position of 
the graft, the upper segment should be placed lingually than the lower one. The intervening soft tissue between 
the 2 segments does not affect the graft stability and the fixture installation.16,29 It is our experience that the 
ventral surface of the distal segment should be folded over the ventral surface of the medial one without subtle 
stretching or kinking the pedicle. Furthermore, compression from paramandibular tissue swelling on the pedicle 
is evitable if the pedicle is aligned lingually or inferiorly to the fibula.29 
 
 2.2.4 The use of miniplates 
 
 Many authors suggested the use of reconstruction plates to secure the free flaps.4,6,16,19 In our patients, 
there was no complication from the use of miniplates. Furthermore, miniplates required only limited periosteal 
elevation in the FFF, allowing minimal vascular damage.29 The use of miniplates seems durable and trouble-
free in this study. 
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 2.3 Disadvantages 
 
There are many limitations in our treatment strategy. First, patient’s general health and lower leg 
conditions (such as a ‘two vessel’ leg, obvious arteriosclerotic changes, pre-existing gait disturbance, 
significant previous leg trauma) limit the candidates for this intervention.15,17,29 The SM-IFFOFR is also 
technically sensitive, requiring proper training and elaborate equipments. Second, skin grafting is obligatory in 
case of a large skin island (> 4 cm in width) or noticeable tension on donor wound closure. Tight closure of a 
wide donor-site wound may cause the compartment syndrome.9,26 Third, there is hair in the flap, yet it usually 
disappears over time. None of our patients expressed displeasure. Forth, the flap is usually bulky and lacks of a 
vestibular sulcus, and subsequently impairs speech, deglutition and dental rehabilitation.6 In this manner, some 
patients need surgical reshaping. Fifth, as mentioned above, its limited height may dictate the use of the ‘double 
barrel’ technique 16,29 or alveolar distraction.30 Finally, donor-site morbidities which include pain, muscle 
weakness, knee and ankle instability and foot numbness are possible, but rare.4,5,16,19,20,29 
 
3. Study limitations 
 
We are aware of the retrospective design, the small size of the series, and a relatively short duration of 
follow-up. However, GMA is rare in France. Many of our patients were immigrants from countries with 
inadequate access to health care. Moreover, we assume that the SM-IFFOFR should increase the cure rate. In 
our department, the method reported herein has been the treatment of choice for extensive tumours over a 
decade. As a result, a randomised controlled trial seems infeasible. It should also be emphasised that with the 
gradual learning curve, careful flap selection and continuing the use of some, but familiar, flaps leads to 
reliable outcomes with few complications.15  
An obvious shortcoming of this series is that one of 2 assessors was the main operator. Thus, our 
report may be at risk of bias. Nonetheless, the second evaluator and the third party counterbalanced this 
possible drawback. Since detailed information on aesthetic and functional outcomes was not consistently 
available in the patient charts, a prospective outcome research on this matter is under way in our institution.  
Notably, this study does not represent a population-based registry in France because there is a 
relatively low incidence of GMA in Whites, and our hospital is for adults only. 
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Conclusion 
 
 Our experiences based on a single team’s experience in a teaching hospital indicated that the SM-
IFFOFR was a plausible way for managing GMA. This method permitted optimal results with relatively rare 
complications. Nonetheless, our report seems not to be a conclusive assessment. A larger number of cases and 
longer follow-op periods remain necessary.  
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Fig. 1 Algorithm for managing mandibular ameloblastoma 
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Fig. 2 A 44-year-old man presented with GMA (LCL defect). A: Preoperative frontal view, B: 
Preoperative CT (axial cut), C: Preoperative CT (3-dimensional), D: Resection specimen. E: 
Postoperative panoramic radiograph at 4 years (Note: one ‘sleepy’ dental implant has been left in situ, 
although it is not used as support for the denture). 
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